Cullinan Oncology to Participate in Upcoming Investor Conferences

November 1, 2022

https://www.globenewswire.com/news-release/2022/11/01/2545284/0/en/Cullinan-Oncology-to-Participate-in-Upcoming-Investor-Conferences.html

CAMBRIDGE, Mass., Nov. 01, 2022 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq:CGEM) (“Cullinan Oncology”) a biopharmaceutical company focused on modality-agnostic targeted oncology for patients with cancer, today announced that its management team will participate in the following investor conferences.

Read more at globenewswire.com

Related news for (CGEM)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.